INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM);UNIVERSITE DE BORDEAUX;UNIVERSITE D'AIX-MARSEILLE;INSTITUT JEAN PAOLI & IRENE CALMETTES;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
发明人:
Philippe Barthelemy,Khalid Oumzil,Arnaud Gissot,Palma Rocchi,Julie Acunzo
申请号：
US14895344
公开号：
US09707250B2
申请日:
2014.06.05
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention concerns an oligonucleotide modified by substitution at the 3′ or the 5′ end by a moiety comprising at least three saturated or unsaturated, linear or branched hydrocarbon chains comprising from 2 to 30 carbon atoms, and the use therefore as a medicament, in particular for use for treating cancer.
